Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.110
+0.040 (3.74%)
At close: Nov 21, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
After-hours: Nov 21, 2024, 4:35 PM EST

Immunic Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
77
Market Cap
99.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 304.34M
PetMed Express 259.34M
Karyopharm Therapeutics 148.44M
FONAR 102.01M
Generation Bio Co. 18.58M
Coya Therapeutics 9.55M
Revenue Rankings